Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
11/2005
11/16/2005EP1492795B1 1- or 3-thia-benzonaphthoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
11/16/2005EP1461036A4 Bis hydrochloride monohydrate salt of rsv fusion inhibitor
11/16/2005EP1450833A4 Anti-hsv agent for inhibiting replication of hsv-1 and hsv-2 and method of producing a substance having anti-hsv activity
11/16/2005EP1363631A4 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
11/16/2005EP1363623B1 Peptide deformylase inhibitors
11/16/2005EP1222191B1 Benzodiazepin derivatives, the production and use thereof
11/16/2005EP1222182B1 Substituted (aminoiminomethyl or aminomethyl) dihydrobenzofurans and benozopyrans
11/16/2005EP1216053B1 Influenza vaccine
11/16/2005EP1206550B1 Proteins derived from white spot syndrome virus and uses thereof
11/16/2005EP1107767B1 Use of selenium for treating systemic inflammatory response syndrome (sirs), and composition for implementing said treatment
11/16/2005EP1068328B1 Treatment and diagnosis of staphylococcal infections
11/16/2005EP0876395B1 Inhibitors of interleukin-1beta converting enzyme
11/16/2005EP0741745B1 Hepatitis b vaccine
11/16/2005CN1697830A 嘧啶衍生物 Pyrimidine derivatives
11/16/2005CN1697662A Water-in-oil emulsions with ethylene oxide groups, compositions, and methods
11/16/2005CN1697655A Methods and compositions using immunomodulatory compounds for treatment and management of cancers and other diseases
11/16/2005CN1697654A Use of COx-2 inhibitors in combination with antiviral agents for the treatment of papilloma virus infections
11/16/2005CN1696301A Process for clavulanic acid production by microbial thallus
11/16/2005CN1227361C Method of expressing thymus peptide alpha by yeast and use thereof
11/16/2005CN1227354C Combination of lactic acid bacteria and its use for prevention and/or treatment of infections and inflammatory conditions
11/16/2005CN1227265C Antibodies to CCR5
11/16/2005CN1227258C Use of azalide antibiotic compositions for treating or preventing bacterial or protozoal infection in mammals
11/16/2005CN1227238C Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidiones as antibacterials
11/16/2005CN1227233C 5-chloro-3-(4-methane sulfonylphenyl)-6-methyl-[2,3'] bipyridine and process for synthesis
11/16/2005CN1227203C A process for preparation of 4,4'-dihalogen-O-hydroxydiphenyl compounds
11/16/2005CN1227035C Conjugates and method for production thereof, and their use for transporting molecules via biological membranes
11/16/2005CN1227032C Vaccines with an LTB adjuvant
11/16/2005CN1227030C Adjuvant composition comprising saponin and an immunostimulatory oligonucleotide
11/16/2005CN1227022C Capsule for treating epidemic parotitis
11/16/2005CN1226998C Controllable released type milk duct suppository
11/16/2005CN1226982C Oil-in-water emulsion comprising micronised biologically active agent and appropriate emulsified system
11/16/2005CN1226981C Medical product package for eradication therapy
11/15/2005US6965022 Methods to identify swine genetically resistant to F18 E. coli associated diseases
11/15/2005US6965018 Antibodies directed to B7-related polypeptide, BSL-2
11/15/2005US6964979 Liver disorders
11/15/2005US6964978 Dissolving with crystal growth inihibitos; drying
11/15/2005US6964974 2,3-oxidosqualene-lanosterol cyclase inhibitors
11/15/2005US6964970 Heterocyclic amines such as 2-benzoyl-1,3,4,9-tetrahydro-2H-pyrido(3,4-b)indole, used preferential inhibitors of fatty acid biosynthesis in bacterial systems; bactericides
11/15/2005US6964968 Respiratory system disorders; cardiovascular disorders; viricides
11/15/2005US6964967 Substituted pyrido[2,3-d]pyrimidines and methods for their use
11/15/2005US6964966 Such as 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(4-amino-3-methyl-1 -piperidinyl)-4-oxo-quinoline-3-carboxylic acid for treatment of systemic or topical infections
11/15/2005US6964965 Corticotropin releasing factor antagonists
11/15/2005US6964960 Indoloquinazolinones
11/15/2005US6964852 Antigenic structural peptide, antigenic and immunogenic compounds, and uses for detecting, preventing and treating an HCV infection
11/15/2005US6964845 Thermostable phage lambda operator mutants for regulating gene expression
11/15/2005US6964769 Molecular antigen array
11/15/2005US6964767 Polypeptides; detecting infections using antibodies
11/15/2005US6964762 Composition and method for stimulating immune response to pathogen using complex adenoviral vector
11/15/2005CA2311988C Crystalline oxathiolane derivatives
11/15/2005CA2179640C Watersoluble azole antifungals
11/14/2005CA2467329A1 Inner core lps epitopes and uses thereof
11/14/2005CA2467312A1 Inhibition of the trnalys3-primed initiation of reverse transcription in hiv-1 by apobec3g
11/10/2005WO2005105743A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof
11/10/2005WO2005105722A1 Crystal comprising (2r)-2-propyloctoic acid and amine
11/10/2005WO2004091666A8 Compositions containing piperacillin and tazobactam useful for injection
11/10/2005WO2004069142A8 Anti-candida agents for the treatment of prion diseases
11/10/2005US20050250950 1,3-oxathiolane nucleoside analogues
11/10/2005US20050250946 Method for the synthesis of 2',3'-dideoxy-2',3'-didehydronucleosides
11/10/2005US20050250939 Process for the production of multiple cross-linked hyaluronic acid derivatives
11/10/2005US20050250933 Vaccines
11/10/2005US20050250846 Non-peptide GnRH agents, pharmaceutical compositions and methods for their use
11/10/2005US20050250845 Pseudopolymorphic forms of a hiv protease inhibitor
11/10/2005US20050250823 Gyrase inhibitors
11/10/2005US20050250811 Such as 14-O-[4-hydroxy-N-valyl-piperidin-3-yl]-sulfanylacetylmutilin
11/10/2005US20050250810 Screening for an enzyme inhibitor of Fab I or Fab K using providing a reaction mixture comprising Fab I or Fab K, crotonyl-ACP and NAPDH or NADH; contacting a candidate compound with the reaction mixture; and detecting inhibition of Fab I or Fab K; bactericides; fungicides; antibiotics; Stapylococcus
11/10/2005US20050250796 Suppress tumor necrosis factor; Crohn's disease; imflammatory bowel disorders; sepsis; autoimmune disease
11/10/2005US20050250790 Novel sulfonic acid derivatives
11/10/2005US20050250758 Nitrosated and nitrosylated H2 receptor antagonist compounds, compositions and methods of use
11/10/2005US20050250744 Pharmaceutically active compounds and methods of use thereof
11/10/2005US20050250727 Use of immunomodulating agents
11/10/2005US20050250716 Immunostimulatory oligodeoxynucleotides
11/10/2005US20050250712 Single dose azithromycin
11/10/2005US20050250707 HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
11/10/2005US20050250679 Conjugates of glycosylated/galactosylated peptide, bifunctional linker, and nucleotidic monomers/polymers, and related compositions and methods of use
11/10/2005US20050250203 Embryonic or stem-like cell lines produced by cross species nuclear transplantation
11/10/2005US20050250196 Recombinant microorganisms expressing an oligosaccharide receptor mimic
11/10/2005US20050250194 slurrying a polysaccharide, which is capable of interacting with silver nitrate and which is in powder form, in NaCl solution in which the polysaccharide is insoluble, contains silver nitrate, filtering off the powder,washing the powder, reducing silver nitrate to silver, drying the powder
11/10/2005US20050250150 outer membrane proteins (OMPs) that, alone or in combination, are capable of inducing protective immunity against Lawsonia intracellularis bacteria
11/10/2005US20050249838 Use of fermented wheat-germ in the feeding and veterinary practice
11/10/2005US20050249798 Gastroretentive drug delivery system comprising an extruded hydratable polymer
11/10/2005US20050249754 CD4+ T-lymphocyte-specific hepatitis C virus epitopes
11/10/2005US20050249746 useful in inducing a protective immune response against NTHi in an immunized human
11/10/2005US20050249722 Monoclonal antibodies with enhanced ADCC function
11/10/2005US20050249715 Lactoperoxidase; antiinflammatory; thrombocytosis, myeloma, Castleman syndrome, cardiac myxoma, glomerulonephritis, rheumatoid arthritis, sepsis, influenza-virus infectious disease
11/10/2005US20050249707 Stimulating an immune response in human or animal, by administering a gene, infected DENDRITIC CELLS; without preventing antigen processing occurring within the infected cell; increase gene expression on the surface of tumour cells; protection against cancer; vaccines
11/10/2005US20050249701 Il-7 Drug substance, composition, preparation and uses
11/10/2005US20050249700 Blockade of T lymphocyte down-regulation associated with CTLA-4 signaling
11/10/2005US20050249663 Coadministration of transport protein with conjugated cobalamin to deliver agents
11/10/2005US20050247312 Medicament dispenser
11/10/2005CA2564596A1 Phep, an amino acid permease of staphylococcus aureus
11/10/2005CA2564175A1 Chemical compounds
11/10/2005CA2562379A1 Veterinary meloxicam formulations suitable for intramammary treatment ofinflammatory disorders in mammals
11/09/2005EP1593684A1 Caprazene as novel compound and derivatives thereof, and caprazol as novel compound and derivatives thereof
11/09/2005EP1593681A1 Tricyclic compound, process for producing the same, and use
11/09/2005EP1593680A1 Fused-ring pyridine derivative, process for producing the same, and use
11/09/2005EP1593673A1 Acrylamide derivative, process for producing the same, and use
11/09/2005EP1593664A1 Nitric esters derivatives of ferulic acid and sulindac with pharmaceutical activity
11/09/2005EP1593394A2 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention
11/09/2005EP1593379A2 Uses of PPAR-gamma agonists in neutrophil-induced diseases
11/09/2005EP1593378A1 Remedy for viral disease
1 ... 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 ... 1798